
NBC News @NBCNews
A nasal vaccine was found to reduce the risk of symptomatic Covid infections by 86% for three months in people who received it as a booster dose, according to a preliminary clinical trial. Researchers also recorded fewer side effects with the new vaccine. https://t.co/FKC7UZm1qc — PolitiTweet.org